Eyenovia Inc (EYEN)

09:49 AM

Eyenovia Stock Tumbles on Termination of Phase III Myopia Study - Yahoo Finance Australia

09:49 AM

08:14 AM

Eyenovia stock downgraded to Neutral, price target set on challenges By Investing.com - Investing.com UK

08:14 AM

07:38 AM

Eyenovia stock plummets following Phase III myopia trial failure - Yahoo! Voices

07:38 AM

Nov 15, 2024

Eyenovia, Inc. Provides Update on Phase 3 CHAPERONE Study - Marketscreener.com

Nov 15, 2024

Nov 15, 2024

Eyenovia to Cut 50% of Workforce After Phase 3 Study Disappoints - MarketWatch

Nov 15, 2024

Nov 15, 2024

Eyenovia to end eye drug study, cut 50% of its workforce - Reuters.com

Nov 15, 2024

Nov 15, 2024

Eyenovia Stock Sinks As Pivotal Trial Fails To Hit Primary Efficacy Goal, Analyst Downgrades Due To Limited Capital And Near Term Upside From Pipeline - AOL

Nov 15, 2024

Nov 15, 2024

Eyenovia Shares Plumb New Depths After Study Failure - MarketWatch

Nov 15, 2024

Nov 15, 2024

Eyenovia Shares Plummet 70% After It Drops Lead Program - BioSpace

Nov 15, 2024

Nov 15, 2024

Eyenovia plunges as late-stage trial for myopia treatment fails - MSN

Nov 15, 2024

Nov 15, 2024

Eyenovia stock plunges after trial setback (EYEN:NASDAQ) - Seeking Alpha

Nov 15, 2024

Nov 15, 2024

Eyenovia discontinues late-stage eye drug study, shares fall - XM

Nov 15, 2024

Nov 15, 2024

ARMISTICE CAPITAL, LLC Acquires Significant Stake in Eyenovia Inc - GuruFocus.com

Nov 15, 2024

Nov 15, 2024

Eyenovia Mulls Options After Phase 3 Study Failure - MarketWatch

Nov 15, 2024

Nov 15, 2024

Eyenovia halts myopia study after missing primary endpoint - Investing.com

Nov 15, 2024

Nov 15, 2024

Eyenovia Third Quarter 2024 Earnings: Misses Expectations - Yahoo Finance

Nov 15, 2024

Nov 15, 2024

Eyenovia Provides Update on Phase 3 CHAPERONE Study - GlobeNewswire

Nov 15, 2024

Nov 15, 2024

Eyenovia's Phase 3 Myopia Drug Trial Fails Primary Endpoint, Company Weighs Options | EYEN Stock News - StockTitan

Nov 15, 2024

Nov 15, 2024

Brookline Capital Downgrades Eyenovia (EYEN) - MSN

Nov 15, 2024

Nov 13, 2024

Eyenovia, Inc. (NASDAQ:EYEN) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 13, 2024

Nov 13, 2024

Eyenovia Inc (EYEN) Q3 2024 Earnings Call Highlights: Strategic Advances Amid Financial Challenges - GuruFocus.com

Nov 13, 2024

Nov 13, 2024

Eyenovia Inc (EYEN) Q3 2024 Earnings Call Highlights: Strategic Advances Amid Financial Challenges By GuruFocus - Investing.com Canada

Nov 13, 2024

Nov 12, 2024

Eyenovia’s Strategic Advances and Q3 Financials - TipRanks

Nov 12, 2024

Nov 12, 2024

Eyenovia, Inc. (EYEN) Reports Q3 Loss, Misses Revenue Estimates - Yahoo Finance

Nov 12, 2024

Nov 12, 2024

Eyenovia Inc Reports Q3 2024 Earnings: EPS of -$0.11 Beats Estim - GuruFocus.com

Nov 12, 2024

Nov 12, 2024

Eyenovia Reports Third Quarter 2024 Financial Results and Provides Corporate Update - The Manila Times

Nov 12, 2024

Nov 12, 2024

Eyenovia Reports Mixed Q3: New Drug Launch Amid Widening Losses; Cash Position at $7.2M | EYEN Stock News - StockTitan

Nov 12, 2024

Nov 07, 2024

Eyenovia to Report Third Quarter 2024 Results on Tuesday, November 12th - The Manila Times

Nov 07, 2024

Oct 28, 2024

EYEN (Eyenovia) Cash Flow from Operations : $-30.23 Mil (TTM As of Jun. 2024) - GuruFocus.com

Oct 28, 2024

Oct 23, 2024

Eyenovia reveals Optejet dispenser benefits in study - Investing.com

Oct 23, 2024

Oct 23, 2024

Eyenovia Announces Publication of Study Demonstrating - GlobeNewswire

Oct 23, 2024

Oct 23, 2024

Eyenovia reveals Optejet dispenser benefits in study By Investing.com - Investing.com UK

Oct 23, 2024

Oct 23, 2024

Eyenovia Announces Publication of Study Demonstrating Favorable Impact on the Ocular Surface of Medication Delivered with the Optejet® - StockTitan

Oct 23, 2024

Oct 19, 2024

Here's Why Eyenovia (EYEN) Is a Great 'Buy the Bottom' Stock Now - MSN

Oct 19, 2024

Oct 18, 2024

EYENEyenovia, Inc. Latest Stock News & Market Updates - StockTitan

Oct 18, 2024

Oct 16, 2024

Presbyopia Market on Track for Major Expansion by 2034, According to DelveInsight | Eyenovia, Orasis Pharma, Ocuphire Pharma, Novartis, Visus Therapeutics - The Globe and Mail

Oct 16, 2024

Oct 16, 2024

Eyenovia Announces Presentation of Phase 3 Clobetasol Study Results at the American Academy of Ophthalmology (AAO) 2024 Expo - The Manila Times

Oct 16, 2024

Oct 16, 2024

Eyenovia Announces Presentation of Phase 3 Clobetasol Study - GlobeNewswire

Oct 16, 2024

Oct 10, 2024

Mydriasis Market Forecasted to Surge in Coming Years, 2024-2034 - openPR

Oct 10, 2024

Oct 10, 2024

Wall Street analysts’ outlook for Eyenovia Inc (EYEN) - SETE News

Oct 10, 2024

Oct 09, 2024

Monitoring Eyenovia Inc (EYEN) after recent insider movements - Knox Daily

Oct 09, 2024

Oct 09, 2024

Eyenovia Inc (EYEN) Q2 2024 Earnings Call Highlights: Strategic Advances Amid Financial Challenges - Yahoo Finance

Oct 09, 2024

Oct 07, 2024

Eyenovia Inc’s results are impressive - US Post News

Oct 07, 2024

Oct 07, 2024

Quarterly Snapshot: Quick and Current Ratios for Eyenovia Inc (EYEN) - The Dwinnex

Oct 07, 2024

Oct 04, 2024

Eyenovia Inc [EYEN] Records 200-Day SMA of $1.0954 - Knox Daily

Oct 04, 2024

Oct 03, 2024

Eyenovia begins manufacturing next-gen drug delivery system - Drug Delivery Business News

Oct 03, 2024

Oct 02, 2024

Top investors say Eyenovia Inc (EYEN) ticks everything they need - SETE News

Oct 02, 2024

Oct 02, 2024

Eyenovia begins Gen-2 Optejet production for Mydcombi By Investing.com - Investing.com South Africa

Oct 02, 2024

Oct 01, 2024

Eyenovia begins Gen-2 Optejet production for Mydcombi - Investing.com

Oct 01, 2024

Oct 01, 2024

Eyenovia Announces Commencement of Manufacturing of its Advanced, Second Generation Optejet Device - The Manila Times

Oct 01, 2024